Multimodal ultrasound features combined with serum CEA and CK19 to predict axillary lymph node metastasis of breast cancer
|更新时间:2025-12-15
|
Multimodal ultrasound features combined with serum CEA and CK19 to predict axillary lymph node metastasis of breast cancer
“In the field of breast cancer research, experts established a model to predict axillary lymph node metastasis through joint analysis of multimodal ultrasound characteristics and serum markers, providing a new scheme for the treatment of breast cancer.”
Yuqing HE, Zizheng WU, Shuai GUO, et al. Multimodal ultrasound features combined with serum CEA and CK19 to predict axillary lymph node metastasis of breast cancer[J]. Oncoradiology, 2025, 34(3): 216-222.
DOI:
Yuqing HE, Zizheng WU, Shuai GUO, et al. Multimodal ultrasound features combined with serum CEA and CK19 to predict axillary lymph node metastasis of breast cancer[J]. Oncoradiology, 2025, 34(3): 216-222. DOI: 10.19732/j.cnki.2096-6210.2025.03.004.
Multimodal ultrasound features combined with serum CEA and CK19 to predict axillary lymph node metastasis of breast cancer